These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16271772)

  • 1. Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
    Balestrieri E; Sciortino MT; Mastino A; Macchi B
    Antiviral Res; 2005 Dec; 68(3):154-62. PubMed ID: 16271772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
    Borroto-Esoda K; Vela JE; Myrick F; Ray AS; Miller MD
    Antivir Ther; 2006; 11(3):377-84. PubMed ID: 16759055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AZT inhibits the transmission of human T cell leukaemia/lymphoma virus type I to adult peripheral blood mononuclear cells in vitro.
    Macchi B; Faraoni I; Zhang J; Grelli S; Favalli C; Mastino A; Bonmassar E
    J Gen Virol; 1997 May; 78 ( Pt 5)():1007-16. PubMed ID: 9152417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of antiretroviral chemokines by human cells cultured with acyclic nucleoside phosphonates.
    Zídek Z; Kmonícková E; Holý A
    Eur J Pharmacol; 2007 Nov; 574(1):77-84. PubMed ID: 17716649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher human T lymphotropic virus (HTLV) provirus load is associated with HTLV-I versus HTLV-II, with HTLV-II subtype A versus B, and with male sex and a history of blood transfusion.
    Murphy EL; Lee TH; Chafets D; Nass CC; Wang B; Loughlin K; Smith D;
    J Infect Dis; 2004 Aug; 190(3):504-10. PubMed ID: 15243924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors.
    Hill SA; Lloyd PA; McDonald S; Wykoff J; Derse D
    J Infect Dis; 2003 Aug; 188(3):424-7. PubMed ID: 12870124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
    Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
    Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL;
    J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.
    Chevalier SA; Meertens L; Pise-Masison C; Calattini S; Park H; Alhaj AA; Zhou M; Gessain A; Kashanchi F; Brady JN; Mahieux R
    Oncogene; 2006 Jul; 25(32):4470-82. PubMed ID: 16532031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on human T-cell leukemia virus type 1 infection in vitro.
    Balestrieri E; Matteucci C; Ascolani A; Piperno A; Romeo R; Romeo G; Chiacchio U; Mastino A; Macchi B
    Antimicrob Agents Chemother; 2008 Jan; 52(1):54-64. PubMed ID: 17967914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
    Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
    J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.
    Teruya H; Tomita M; Senba M; Ishikawa C; Tamayose M; Miyazato A; Yara S; Tanaka Y; Iwakura Y; Fujita J; Mori N
    Retrovirology; 2008 Sep; 5():86. PubMed ID: 18808681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell leukemia virus type 1 up-regulation after simian immunodeficiency virus-1 coinfection in the nonhuman primate.
    Traina-Dorge VL; Martin LN; Lorino R; Winsor EL; Beilke MA
    J Infect Dis; 2007 Feb; 195(4):562-71. PubMed ID: 17230416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir treatment at 30 mg/kg/day can inhibit cortical bone mineralization in growing rhesus monkeys (Macaca mulatta).
    Castillo AB; Tarantal AF; Watnik MR; Martin RB
    J Orthop Res; 2002 Nov; 20(6):1185-9. PubMed ID: 12472227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tenofovir double-dose in treatment-experienced HIV-infected patients: the TENOPLUS study.
    Dominguez S; Ghosn J; Peytavin G; Izzedine H; Wirden M; Ktorza N; Miller M; Aubron-Olivier C; Trylesinski A; Calvez V; Deray G; Katlama C
    J Med Virol; 2007 Feb; 79(2):105-10. PubMed ID: 17177308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
    Casoli C; Pilotti E; Bertazzoni U
    AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Natural history of human T-lymphotropic virus type 1 (HTLV-1) infection].
    Okayama A
    Rinsho Byori; 2005 Sep; 53(9):837-44. PubMed ID: 16235837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta enhances human T-cell leukemia virus type I infection.
    Moriuchi M; Moriuchi H
    J Med Virol; 2002 Jul; 67(3):427-30. PubMed ID: 12116037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphonated carbocyclic 2'-oxa-3'-azanucleosides as new antiretroviral agents.
    Chiacchio U; Rescifina A; Iannazzo D; Piperno A; Romeo R; Borrello L; Sciortino MT; Balestrieri E; Macchi B; Mastino A; Romeo G
    J Med Chem; 2007 Jul; 50(15):3747-50. PubMed ID: 17580846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.